期刊文献+

^(90)Sr/^(90)Yβ射线腔内照射治疗前列腺增生症的临床应用研究 被引量:3

The effect of^(90)Sr/^(90)Yβ-rays of benign prostatic hyperplasia
下载PDF
导出
摘要 目的 观察 90 Sr/90 Yβ射线腔内治疗前列腺增生症的临床疗效。方法 将 90 Sr/90 Y治疗器活性区置于尿道前列腺段 ,实施β射线腔内照射 ,剂量为 30~ 50 Gy,治疗 37例前列腺增生病人 ,治疗后随访 3个月。结果 治疗 2 w后 ,2 6例患者临床症状明显减轻 ,7例有所好转 ,4例改善不明显。治疗前后最大尿流率、膀胱残余尿、国际前列腺症状评分及前列腺体积均发生明显的变化 (P<0 .0 1 )。结论 放射性核素 90 Sr/90 Y腔内治疗前列腺增生症效果显著 。 Objective To investigate the effect of 90 Sr/ 90 Y β rays on benign prostatic hyperplasia(BPH) Methods In order to carry out β rays intracavitary irradiation, the active area of the applicator was located into prostate gland section of urethra in 37 patients The dose was 300Gy in each patient who was observed for 3 monthes Results After two weeks 26 cases were remarkably improved, 7 cases were slightly improved and 4 cases were ineffective There was significant difference on MFR, PVR, I PSS and volumn of prostate gland before and after treatment(P<0 01) Conclusions Clinical tests indicate that the 90 Sr/ 90 Y prostatic hyperplasia applicators provide a safe, effective, non invasive and economical therapeutic method for BPH It is especially applicable for older and high risk patients
出处 《中国老年学杂志》 CAS CSCD 北大核心 2002年第1期29-30,共2页 Chinese Journal of Gerontology
关键词 前列腺增生症 前列腺增生治疗器 Β射线 临床应用 腔内照射 Benign prostatic hyperplasia Prostatic hyperplasia applicator Radiation
  • 相关文献

参考文献3

二级参考文献1

  • 1李士骏,电离辐射剂量学(第2版),1986年,118页

共引文献144

同被引文献22

  • 1莫曾南,黄恒前,隆电熙,杨占斌.前列腺光子治疗机治疗良性前列腺增生近期疗效观察(附30例报告)[J].中华男科学杂志,2004,10(10):764-766. 被引量:2
  • 2马景禄,刘君丽.^(192)Ir尿道内放射治疗良性前列腺增生31例报道[J].中华男科学杂志,2005,11(4):303-303. 被引量:4
  • 3Mansfield CM, Komamick LT, Schwartz GF, et al. Perioperative implantation of iridium- 192 as the boost technique for stage Ⅰand Ⅱ breast cancer: results of a 10 - year study of 655 patients[ J ]. Radiology, 1994,192 (1): 33-36
  • 4Koot RW, Maarouf M, Hulshof MC, et al. Brachytherapy: Results of two different therapy strategies for patients wit primary glioblastoma multiforme[ J ]. Cancer, 2000,88 (12): 2796-2802
  • 5Katz A, Eifel PJ. Quantification of intraeavitary brachytherapy parameters and correlation with outcome in patients with carcinoma of the cervix [ J ]. Int J Radiat Oncol Biol Phys, 2000,48(5): 1417-1425
  • 6Henschke UK. Permanent interistial implant with radioacvtive seeds of long and low energy[J ]. Minerva Med, 1967,58 (99):4535-4536
  • 7Malhado N, Kao J De, Wyngaert JK, et al. Postimplant dosimetry dosimetry for 125Ⅰ Prostate implants: definitions and factors af fecting outcome[ J ]. Int Radiat Oncol Biol Phys, 2000, 48 (3):899-906
  • 8Maisin H,Wambersie A. Curietherapy in breast cancer of stages Ⅰ and Ⅱ by radium implant or 198Au Seeds[J]. Panminerva Med, 1976,18(1 - 2) :50-59
  • 9Halligan JB, Stelzer KJ, Rostomily RC, et al. Operation and permanent low activity 125Ⅰ brachytheraphy for recurrent highgrade astrocytomas[J]. Berger MS Int J Radiat Oncol Biol Phys,1996,35 (3): 541-547
  • 10Fareh J,Martel R,Kermani P,et al.Cellular effects of beta-particle delivery on vascular smooth muscle cells and endothelial cells:a dose-response study[J].Circulation,1999,99(11):1477-1484.

引证文献3

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部